At the Intimate Wellness Institute (IWIVA), we believe that every woman deserves access to the most advanced and comprehensive care for her intimate health. This belief drives our unwavering commitment to innovation and continuous improvement. Under the leadership of Dr. Nathan Guerette, an internationally recognized expert in Urogynecology and Pelvic Reconstructive Surgery, we are constantly pushing the boundaries of what’s possible, ensuring our patients receive the highest quality, most effective treatments available.
Dr. Guerette’s passion for improving women’s lives is the driving force behind our commitment to innovation. His expertise and dedication have established IWIVA as a leading center for Aesthetic Gynecology and Advanced Women’s Care in the Mid-Atlantic region.
The mission at IWIVA is to empower women to reclaim their intimate health and confidence. This requires a commitment to continuous learning, innovation, and a patient-centered approach. We are constantly striving to improve our techniques and technologies, ensuring that our patients receive the best possible care.
Prospective multi-center trial for diVa vaginal laser for Atrophic Vaginitis. Lead Investigator and Protocol developer.
August 2016 – present.
Prospective multi-center trial for diVa vaginal laser for Stress Urinary Incontinence. Lead Investigator and Protocol developer.
August 2016 – present.
Ministop single incision sling pilot U.S. trial. CL Medical.
May 2015 – present. Lead investigator and protocol developer.
I-stop retropubic and transobturator sling U.S. database.
May 2015 – present. Developed and house database. CL Medical
Y for Her: RCT of Upsylon vs. Restorelle Y mesh for Robotic ASC. Lead Investigator and Protocol developer.
December 2014 – present
Amphora RF for OAB Treatment.
May 2015 – Present. Investigator
ROSE Study: Macroplastique for Treatment of SUI. Investigator.
March 2014 – present
AMS ISPRINT perineal support device.
October 2012-present. Investigator
EMBRACE Trial: FDA 522 Analysis for Anterior Elevate.
January 2015 – present. Investigator and Protocol developer
HARMONY Trial: FDA 522 Analysis for Posterior Elevate.
January 2015 – present. Investigator and Protocol developer
AMS Capture Postmarket Anaylsis: MiniarcPro.
Feb 2013 – Present. Investigator.
Altis Minisling Prospective Study.
August 2011 – Present. Investigator
Floroscopic Evaluation of Vaginal Axis with Five Vault Suspension Techniques Compared to Normal.
October 2008 Primary Investigator
MiniarcTM sling: Long-term effectiveness trial.
Oct 2007 Primary Investigator
A Randomized, Evaluator-blinded, Multi-center Study Comparing the Efficacy and Safety of ZUIDEXTM with Contigen® in Female Patients with Stress Urinary Incontinence.
June 2004 – July 2005. Investigator.
Open Label Study of the Efficacy and Safety of 5 and 10 mg Vesicare™ in Patients with Overactive Bladder Symptoms.
June 2004 – July 2005. Investigator.
Prospective, Randomized Veritas™ Collagen Matrix for Cystocele Repair Post-marketing Study.
August 2003 – Present. Investigator.
A Multicenter Evaluation of the Kolpexin™ Vaginal Spheres in Females with Vaginal Prolapse.
December 2001 – July 2005. Investigator.
A United States Multi-Center Prospective Study of the Utility and Effectiveness of the American Medical Systems Subfascial Hammock.
August 2003 – July 2005. Sub-investigator.
Assessment of the Efficacy of Tolterodine ER Versus Placebo for the Symptom of Urgency and The Improvement in Bladder Condition.
September 2002 – June 2003. Sub-investigator.
A Multi-Center, Double-Blind, Placebo-Controlled, Dose-Titration Study of Oxybutynin Transdermal Systems in Patients with Overactive Bladder.
August 2003 – October 2003. Sub-Investigator.
Clinical Investigation of an Adjustable Continence Therapy (ACT) Periurethral Prosthetic System for Treatment of Female Stress Urinary Incontinence with or without Hypermobility.
September 2002- July 2005. Sub-investigator.
Randomized, Double-Blind, Placebo-Controlled, Dose-finding Study to Evaluate the Effects of a Partial Alpha1A/1L-Adrenoceptor Antagonist, Ro115-1240, in Women with Stress Urinary Incontinence or Mixed Urinary Incontinence.
February 2002 – February 2004. Sub-investigator.
Open-Label Extension for Treatment of Incontinent Patients Who Have Completed the Ro115-1240 Study.
August 2002 – June 2004. Sub-investigator.
A Prospective, Double-Blind, Randomized Study of the Effect of Premarin Vaginal Cream and Low-Dose Premarin/MPA on Dyspareunia, Atrophic Vaginitis, Sexual Function, Quality of Life, and Genital Blood Flow
April 2001 – September 2003. Sub-investigator.
Phase III, Multinational, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study To Evaluate the Efficacy and Safety of Transdermal Testosterone (300 mg/day) for 24 Weeks and Safety for a further 28 weeks in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder on Concurrent Oral Hormone Replacement Therapy.
March 2002 – July 2005. Sub-investigator.
Prospective, Non-Randomized Pilot Study to Evaluate Polymer Technologies, Inc.’s Polymer 47K Urethral Bulking Agent Implant to Treat Stress Urinary Incontinence.
June 2000 – July 2005. Sub-investigator.
Effects of estrogen on Protein Synthesis in Arteries. Women’s Health Initiative Study. Research Division, AHA, University of Vermont.
1992-93. Student investigator
At IWIVA, we are not content to rest on our laurels. We are committed to ongoing research, development, and improvement. We believe that by continuously pushing the boundaries of what’s possible, we can transform the lives of women throughout the region and beyond.
We invite you to experience the difference that cutting-edge care can make. Contact us today to schedule a consultation and learn more about how we can help you achieve optimal intimate wellness and confidence. We are here to support you every step of the way.
"I think the thing that stood out most about the office is that I really felt like, Dr. Guerette understood what I was talking about when I started talking about some of the bladder issues I had. And number two,everybody just seemed really very caring. I really appreciated that."
"I would recommend Dr. G and Jennifer because they are the best. They listen, they're very patient and they really know their stuff! I would like to add that since I have, found Dr. G and Jennifer, I have learned a lot about myself and what I'm going through, that I'm not the only one and there's help so don't have to suffer in silence any longer."
"When I was here, I felt completely heard. I felt, seen and understood. You guys really helped me. You made me not feel, you made me feel like a human. You didn't make me feel like I was a patient."
"I have a much better idea of what's going on with my body and the things that I need to do to, help be more comfortable, have a better quality of life."
